Belgium· BE-AMP-SAM173284-00

Rhinocort Turbohaler 100 100 µg/dose

A budesonide product containing budesonide, registered in Belgium by AstraZeneca. The same ATC class is registered in 11 of our 19 countries.

ATC R01AD05

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about budesonideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Budesonide is registered in 11 of 19 countries.

Countries holding a registration under ATC R01AD05 (budesonide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search budesonide products by name

Budesonide · ATC R01AD05

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Budesonide
Manufacturer: AstraZeneca
Country: Belgium (BE)
ATC code: R01AD05
ATC class: Budesonide
Defined daily dose: 0.2 mg, N
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
1236694
be_apb
0745661

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for budesonide.

Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check budesonide against other medicines How interaction checks work

Budesonide · interactions on record

89 records

89 moderate

Most severe, free to view

ClotrimazoleA01AB18moderate
AprepitantA04AD12moderate
MiconazoleA07AC01moderate
LonafarnibA16AX20moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Budesonide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All budesonide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Budenofalk, Budo-San
Bulgaria · Airbudenid, Буденофалк
Cyprus · Axelovert, Biosonide
Czechia · Budenofalk, Budenofalk Uno
Germany · Aquacort, Budapp Nasal
Denmark · Benarhin, Budenofalk
Estonia · Budesonid Sandoz, Budesonide
Spain · Budena, Budesonida
Finland · Budenofalk, Budesonid Easyhaler Orion
France · Budésonide Arrow, Budesonide Biogaran
United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
Greece · Aurid, Axelovert
Croatia · Budelin Novolizer, Budosan
Hungary · Budenofalk, Budesonid Easyhaler
Ireland · Budenofalk, Budesonide Azure
Iceland · Budesonide Stada, Cortiment
Italy · Aircort, Bidien
Liechtenstein · Jorveza, Kinpeygo
Lithuania · Budenofalk, Budesonide Ferring
Luxembourg · Budenofalk, Budesonide Eg
Latvia · Budenofalk, Budesonid Sandoz
Malta · Budesonida Aldo-Unión, Budesonide Azure
Netherlands · Budenofalk, Budenofalk Schuim
Norway · Budenofalk, Budesonid Medical Valley
Poland · Bds N, Benodil
Portugal · Aeromax, Budenofalk
Romania · Budenofalk, Budenofalk Uno
Sweden · Budaxiro, Budenofalk
Slovenia · Budenofalk, Budesonid Easyhaler Orion
Slovakia · Budelin Novolizer, Budenofalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bc433bc2-ff9f-4255-b812-fb6558c57666
GET /v1/drugs/bc433bc2-ff9f-4255-b812-fb6558c57666?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal powder",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Rhinocort Turbohaler 100 100 µg/dose",
  "name_fr": "Rhinocort Turbohaler 100 100 µg/dose",
  "name_nl": "Rhinocort Turbohaler 100 100 µg/dose",
  "amp_code": "SAM173284-00",
  "strengths": [
    "100.0000",
    "100.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Budesonide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Budesonide",
  "authorisation_numbers": [
    "BE173284"
  ]
}

API reference MCP server Plans

See everything about budesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console